Absolute bioavailability of fluconazole suspension in intensive care unit patients

Journal of Infectious Disease Pharmacotherapy

Volumn 5, Issue 1, 2001, Pages 27-35

  Zhou, W ^a   Nightingale, C H ^a   Davis, G A ^a   Nicolau, D P ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

Fluconazole; Intensive care unit; Pharmacokinetics

Indexed keywords

FLUCONAZOLE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG INFUSION; EVALUATION; FEMALE; GASTROINTESTINAL MOTILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LIVER FUNCTION; MALE; NONHUMAN; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0035197002     PISSN: 10687777     EISSN: None     Source Type: Journal    
DOI: 10.1300/j100v05n01_02     Document Type: Article

References (9)

1. New developments in the diagnosis and management of invasive fungal infections
2. Role of newer azoles in surgical patients
3. Nosocomial fungal infections: Candidemia
4. Antifungal agents. Part II. The azoles
5. Bioavailability of fluconazole administered via a feeding tube in intensive care unit patients
6. Bioavailability of fluconazole in surgical intensive care unit patients: A study comparing route of administration
7. Pharmacokinetics of fluconazole in trauma patients receiving total enteral nutrition via post-pyloric enteral access tube versus intravenous
8. Characterization and quantification of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis model